---
schema_version: "secwatch.filing_event.v1"
accession: "0001193805-23-000799"
form_type: "8-K"
ticker: null
cik: "0001497504"
company_name: "PLx Pharma Winddown Corp."
filed_at: "2023-05-26T23:59:59+00:00"
generated_at: "2026-06-14T12:51:00.350709+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# PLx Pharma Winddown Corp. completes sale of substantially all assets following Chapter 11 approval

## Summary
- Sale to PLx Acquisition Company, LLC consummated on May 26, 2023, after Bankruptcy Court approval on May 25.
- Company changed name to PLx Pharma Winddown Corp.; common stock trades on OTC Pink under PLXPQ.
- Amendment to Asset Purchase Agreement clarified excluded assets, inventory definitions; Buyer Deficiency Claim eliminated.
- Monthly operating reports filed for period April 13-30, 2023, covering initial bankruptcy period.
- Company cautions trading in common stock is highly speculative; holders may receive no recovery.

## SEC filing metadata
- accession: 0001193805-23-000799
- form_type: 8-K
- cik: 0001497504
- company_name: PLx Pharma Winddown Corp.
- filed_at: 2023-05-26T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 1.01, 1.03, 2.01, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1497504/000119380523000799/0001193805-23-000799-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1497504/000119380523000799/e618671_8k-plx.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193805-23-000799
- JSON: https://secwatch.observer/filing/0001193805-23-000799.json
- Plain text: https://secwatch.observer/filing/0001193805-23-000799.txt

## Key facts
- Distress & Bankruptcy
  PLx Pharma Winddown Corp. entered chapter 11 in United States Bankruptcy Court (petition 2023-05-26).
  - Proceeding: chapter 11
  - Court: United States Bankruptcy Court
  - Petition: 2023-05-26
  source text: Item 1.03 Bankruptcy or Receivership. The information set forth under Item 2.01 of this Current Report on Form 8-K is incorporated herein by reference.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1497504/000119380523000799/0001193805-23-000799-index.htm
- Governance Changes
  PLx Pharma Winddown Corp.: Company changed its name to 'PLx Pharma Winddown Corp.' (effective 2023-05-26).
  - Change: charter amendment
  - Effective: 2023-05-26
  source text: On May 26, 2023, the Company filed an amendment to its Amended and Restated Certificate of Incorporation (the "Charter Amendment") with the Secretary of State of the State of Delaware in order to change its name to "PLx Pharma Winddown Corp.".
  evidence_url: https://www.sec.gov/Archives/edgar/data/1497504/000119380523000799/0001193805-23-000799-index.htm
- M&A Transactions
  PLx Pharma Winddown Corp. completed a disposition involving PLx Acquisition Company, LLC (closed 2023-05-26).
  - Action: disposition
  - Counterparty: PLx Acquisition Company, LLC
  - Closing: 2023-05-26
  source text: Pursuant to the Asset Purchase Agreement, the Sale was consummated on May 26, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1497504/000119380523000799/0001193805-23-000799-index.htm
- Material Agreements
  PLx Pharma Winddown Corp. amended Amendment No. 1 to the Asset Purchase Agreement with PLx Acquisition Company, LLC (effective 2023-05-26).
  - Action: amendment
  - Agreement: asset purchase
  - Counterparty: PLx Acquisition Company, LLC
  - Effective: 2023-05-26
  source text: orse asset purchase agreement (the “Asset Purchase Agreement”) with PLx Acquisition Company, LLC, a wholly-owned subsidiary of Greenwood Brands, LLC (the “Purchaser”), to sell substantially all of the Sellers’ assets to the Purchaser pursuant
  evidence_url: https://www.sec.gov/Archives/edgar/data/1497504/000119380523000799/0001193805-23-000799-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.